| Actos EU/1/00/150/005 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actos EU/1/00/150/011 |
Pioglitazone |
Takeda Pharma A/S |
— |
| Actos 15 mg tablets EU/1/00/150/001 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actos 15 mg tablets EU/1/00/150/003 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actos 30 mg tablets EU/1/00/150/004 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actos 30 mg tablets EU/1/00/150/006 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actraphane EU/1/02/229/001-035 |
Insulin human |
Novo Nordisk A/S |
— |
| Actraphane 30 40 IU/ml Suspension for injection EU/1/02/229/036-037 |
Insulin human, Insulin human |
Novo Nordisk A/S |
— |
| Actrapid EU/1/02/230/001-015 |
Insulin human |
Novo Nordisk A/S |
— |
| Actrapid EU/1/02/230/016-017 |
Insulin human |
Novo Nordisk A/S |
— |
| Acular 0.5% w/v Eye Drops, solution PA1824/015/001 |
Ketorolac trometamol |
AbbVie Limited |
Marketed |
| Acular 0.5% w/v Eye Drops, solution PPA1463/200/001 |
Ketorolac trometamol |
IMED Healthcare Ltd. |
Marketed |
| ACULAR 0.5% w/v Eye drops, solution PPA0465/287/001 |
Ketorolac trometamol |
PCO Manufacturing Ltd. |
— |
| Adaluzis 500mg Powder for concentrate for solution for infusion PA23450/003/001 |
Ceftobiprole medocaril sodium |
Advanz Pharma Limited |
Not marketed |
| ADASUVE 4.5 mg inhalation powder, pre-dispensed EU/1/13/823/001 |
Loxapine |
Ferrer Internacional, S.A |
— |
| ADASUVE 9.1 mg inhalation powder, pre-dispensed EU/1/13/823/002 |
Loxapine |
Ferrer Internacional, S.A |
— |
| ADCETRIS 50 mg powder for concentrate for solution for infusion EU/1/12/794/001 |
Brentuximab vedotin |
Takeda Pharma A/S |
— |
| Adcirca (previously Tadalafil Lilly) EU/1/08/476/001-004 |
Tadalafil |
Eli Lilly Nederland B.V. |
— |
| Adcirca 20 mg film-coated tablets EU/1/08/476/005-06 |
Tadalafil |
Eli Lilly Nederland B.V. |
— |
| Addiphos concentrate for solution for infusion PA2059/024/001 |
Potassium dihydrogen phosphate, Potassium hydroxide, Disodium phosphate dihydrate |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Additrace N concentrate for solution for infusion PA2059/023/002 |
Chromic chloride hexahydrate, Copper chloride dihydrate, Ferric chloride hexahydrate, Manganese chloride tetrahydrate, Potassium iodide |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Adempas 0.15 mg/mL granules for oral suspension EU/1/13/907/021 |
Riociguat |
Bayer AG |
— |
| Adempas 0.5 mg film-coated tablets EU/1/13/907/001-003 |
Riociguat |
Bayer AG |
— |
| Adempas 1 mg film-coated tablets EU/1/13/907/004-006 |
Riociguat |
Bayer AG |
— |
| Adempas 1.5 mg film-coated tablets EU/1/13/907/007-009 |
Riociguat |
Bayer AG |
— |
| Adempas 2 mg film-coated tablets EU/1/13/907/010-012 |
Riociguat |
Bayer AG |
— |
| Adempas 2.5 mg film-coated tablets EU/1/13/907/013-015 |
Riociguat |
Bayer AG |
— |
| Adenocor 3 mg/ml solution for injection PA0540/139/001 |
Adenosine |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Adenosine 3 mg/ml solution for injection in pre-filled syringe PA2059/004/001 |
Adenosine |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Adenuric 80 mg film-coated tablets EU/1/08/447/001-002 |
Febuxostat |
Menarini International Operations Luxembourg S.A. |
— |
| Adenuric120 mg film-coated tablets EU/1/08/447/003-004 |
Febuxostat |
Menarini International Operations Luxembourg S.A. |
— |
| Adizem-SR 120 mg Prolonged Release Capsules PA1688/001/002 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Adizem-SR 180 mg Prolonged Release Capsules PA1688/001/003 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Adizem-SR 90 mg Prolonged Release Capsules PA1688/001/001 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| ADIZEM-XL 120mg prolonged release capsules PA1688/001/004 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| ADIZEM-XL 180mg prolonged release capsules PA1688/001/005 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| ADIZEM-XL 240 mg prolonged release capsules PA1688/001/006 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| ADIZEM-XL 300 mg prolonged release capsules PA1688/001/007 |
Diltiazem hydrochloride |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) EU/1/09/578/001 |
Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1) |
GlaxoSmithKline Biologicals S.A. |
— |
| Adrenaline (Epinephrine) 1 mg/10 ml (1:10,000) Solution for Injection in Pre-Filled Syringe PA1968/002/001 |
Adrenaline tartrate |
Laboratoire Aguettant |
Marketed |
| Adrenaline (Epinephrine) 1:1,000 Solution for Injection PA0073/035/001 |
Adrenaline (epinephrine) |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Adrovance 70 mg/2800 IU tablets EU/1/06/364/001-004 |
Vitamin d3, Alendronic acid |
N.V. Organon |
— |
| Adrovance 70 mg/5600 IU tablets EU/1/06/364/006-008 |
Vitamin d3, Alendronic acid |
N.V. Organon |
— |
| Adtralza 150 mg solution for injection in pre-filled syringe EU/1/21/1554/001-003 |
Tralokinumab |
LEO Pharma A/S |
— |
| Adtralza 300 mg solution for injection in pre-filled pen EU/1/21/1554/004-005 |
Tralokinumab |
LEO Pharma A/S |
— |
| Advagraf 0.5 mg prolonged-release hard capsules EU/1/07/387/001-002 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 0.5 mg prolonged-release hard capsules EU/1/07/387/1-2 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 1 mg prolonged-release hard capsules EU/1/07/387/003-006 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 1 mg prolonged-release hard capsules EU/1/07/387/3-6 |
Tacrolimus |
Astellas Pharma Europe BV |
— |
| Advagraf 3 mg prolonged-release hard capsules EU/1/07/387/011-013 |
Tacrolimus |
Astellas Pharma Europe BV |
— |